z-logo
open-access-imgOpen Access
Integrated analysis of whole genome exon array and array‐comparative genomic hybridization in gastric and colorectal cancer cells
Author(s) -
Furuta Kazuyuki,
Arao Tokuzo,
Sakai Kazuko,
Kimura Hideharu,
Nagai Tomoyuki,
Tamura Daisuke,
Aomatsu Keiichi,
Kudo Kanae,
Kaneda Hiroyasu,
Fujita Yoshihiko,
Matsumoto Kazuko,
Yamada Yasuhide,
Yanagihara Kazuyoshi,
Sekijima Masaru,
Nishio Kazuto
Publication year - 2012
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/j.1349-7006.2011.02132.x
Subject(s) - exon , biology , comparative genomic hybridization , cancer , microbiology and biotechnology , genetics , cancer research , gene , genome
Whole genome‐scale integrated analyses of exon array and array‐comparative genomic hybridization are expected to enable the identification of unknown genetic features of cancer cells. Here, we evaluated this approach in 22 gastric and colorectal cancer cell lines, focusing on protein kinase genes and genes belonging to the cadherin–catenin family. Regarding alternative splicing patterns, several cancer cell lines predominantly expressed isoform 1 of protein kinase A catalytic subunit beta ( PRKACB ). Paired gastric cancer specimens demonstrated that isoform 1 of PRKACB was a novel cancer‐related variant transcript in gastric cancers. In addition, the exon array analysis clearly identified exon 3 or exon 3–4 skipping in catenin beta 1 , a short intron insertion with exon 9 skipping in CDH1 , and a deletional transcript of CDH13 . These abnormal transcripts were shown to have arisen from small genomic deletions. Meanwhile, an integrated analysis of 11 gastric cancer cell lines revealed that four cell lines amplified fibroblast growth factor receptor 2, with truncated forms observed in two of the cell lines. Gene amplification, and not the truncated form, was found to determine the sensitivity to a fibroblast growth factor receptor inhibitor, indicating that our cell line panel might be useful for cell‐based evaluations of specific inhibitors. Using an integrated analysis, we identified several abnormal transcripts and genomic alterations in gastric and colorectal cancer cells. Our approach might enable genetic changes to be identified more efficiently, and the present results warrant further investigation using clinical samples and integrated analyses. ( Cancer Sci 2012; 103: 221–227)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here